A novel immuno-oncology algorithm measuring tumor microenvironment to predict response to immunotherapies
Immune checkpoint inhibitor (ICI) therapies can improve clinical outcomes for patients with solid tumors, but relatively few patients respond. Because ICI therapies support an adaptive immune response, patients with an active tumor microenvironment (TME) may be more likely to respond, and thus bioma...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Jezik: | English |
| Izdano: |
Elsevier
2021-03-01
|
| Serija: | Heliyon |
| Teme: | |
| Online dostop: | http://www.sciencedirect.com/science/article/pii/S2405844021005430 |